Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Venook

Showing results (131-140 of 246) with videos related to

Pageof 25
Sort By:
BMC Cancer|March 15, 2019
Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trialErin L Van Blarigan, Hilary Chan, Katherine Van Loon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2019
Reply to S. SorscherFederico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Cancer Survivorship : Research and Practice|November 6, 2022
Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort studyAnya L Greenberg, Irina V Tolstykh, Katherine Van Loon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumorsMatthew H Kulke, Emily K Bergsland, David P Ryan, et al.
Liver Cancer|May 29, 2015
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinomaAbby B Siegel, Anthony B El-Khoueiry, Richard S Finn, et al.
Annals of Surgical Oncology|February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial designMatthew H G Katz, Robert Marsh, Joseph M Herman, et al.
Cancer|August 31, 2023
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)Justin C Brown, Chao Ma, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2019
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient OutcomeFederico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)Emily K Bergsland, Susan Geyer, Timothy R Asmis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomesLee M Ellis, David S Bernstein, Emile E Voest, et al.
Pageof 25

Showing results (131-140 of 246) with videos related to

Sort By:
Pageof 25
BMC Cancer|March 15, 2019
Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trialErin L Van Blarigan, Hilary Chan, Katherine Van Loon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2019
Reply to S. SorscherFederico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Cancer Survivorship : Research and Practice|November 6, 2022
Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort studyAnya L Greenberg, Irina V Tolstykh, Katherine Van Loon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumorsMatthew H Kulke, Emily K Bergsland, David P Ryan, et al.
Liver Cancer|May 29, 2015
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinomaAbby B Siegel, Anthony B El-Khoueiry, Richard S Finn, et al.
Annals of Surgical Oncology|February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial designMatthew H G Katz, Robert Marsh, Joseph M Herman, et al.
Cancer|August 31, 2023
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)Justin C Brown, Chao Ma, Qian Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2019
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient OutcomeFederico Innocenti, Fang-Shu Ou, Xueping Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)Emily K Bergsland, Susan Geyer, Timothy R Asmis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomesLee M Ellis, David S Bernstein, Emile E Voest, et al.
Pageof 25